Healthlink On Air

“The female Viagra” is a misleading name for a new drug for women struggling with low or no sexual desire, and while it shows some promise, it comes with limitations, says “The female Viagra” is a misleading name for a new drug for women struggling with low or no sexual desire, and while it shows some promise, it comes with limitations, says Renee Mestad, MD, Renee Mestad, MD,  division chief of general obstetrics and gynecology at  division chief of general obstetrics and gynecology at Upstate Medical University Upstate Medical University in Syracuse. Flibanserin, marketed as Addyi, aims to treat the complex problem of female sexual dysfunction by stimulating brain chemicals to enhance desire, while Viagra treats men with sexual desire who are limited by erectile dysfunction. in Syracuse. Flibanserin, marketed as Addyi, aims to treat the complex problem of female sexual dysfunction by stimulating brain chemicals to enhance desire, while Viagra treats men with sexual desire who are limited by erectile dysfunc